NZ176716A - 2-bromo-6b-fluoropregna-1,4-diene-3,20-diones - Google Patents

2-bromo-6b-fluoropregna-1,4-diene-3,20-diones

Info

Publication number
NZ176716A
NZ176716A NZ176716A NZ17671675A NZ176716A NZ 176716 A NZ176716 A NZ 176716A NZ 176716 A NZ176716 A NZ 176716A NZ 17671675 A NZ17671675 A NZ 17671675A NZ 176716 A NZ176716 A NZ 176716A
Authority
NZ
New Zealand
Prior art keywords
fluoropregna
diones
diene
bromo
Prior art date
Application number
NZ176716A
Other languages
English (en)
Inventor
M Riva
L Toscano
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of NZ176716A publication Critical patent/NZ176716A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ176716A 1974-02-27 1975-02-20 2-bromo-6b-fluoropregna-1,4-diene-3,20-diones NZ176716A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8928/74A GB1499822A (en) 1974-02-27 1974-02-27 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones
GB2998474 1974-07-05
GB3294574 1974-07-25
GB4998274 1974-11-19

Publications (1)

Publication Number Publication Date
NZ176716A true NZ176716A (en) 1978-07-10

Family

ID=27447687

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ176716A NZ176716A (en) 1974-02-27 1975-02-20 2-bromo-6b-fluoropregna-1,4-diene-3,20-diones

Country Status (18)

Country Link
JP (1) JPS5614677B2 (es)
AR (1) AR218601A1 (es)
BE (1) BE826030A (es)
CA (1) CA1064476A (es)
CH (1) CH608243A5 (es)
DE (3) DE2508136C3 (es)
DK (1) DK144068C (es)
ES (3) ES435067A1 (es)
FI (1) FI56188C (es)
FR (1) FR2261776B1 (es)
GB (1) GB1499822A (es)
IE (1) IE42112B1 (es)
LU (1) LU71908A1 (es)
NO (1) NO144527C (es)
NZ (1) NZ176716A (es)
RO (1) RO78881A (es)
SE (1) SE410736B (es)
YU (3) YU108281A (es)

Also Published As

Publication number Publication date
DE2508136A1 (de) 1975-10-30
DE2533323A1 (de) 1976-02-12
DE2533377C3 (de) 1979-08-02
FR2261776A1 (es) 1975-09-19
IE42112L (en) 1975-08-27
CH608243A5 (en) 1978-12-29
ES455934A1 (es) 1978-05-01
SE7502146L (es) 1975-08-28
AR218601A1 (es) 1980-06-30
DE2533377A1 (de) 1976-02-05
DK144068B (da) 1981-11-30
IE42112B1 (en) 1980-06-04
CA1064476A (en) 1979-10-16
FI56188C (fi) 1979-12-10
DE2533377B2 (de) 1978-11-16
ES455933A1 (es) 1978-05-01
YU108481A (en) 1982-02-28
DE2533323C3 (de) 1979-07-12
NO144527C (no) 1981-09-23
ES435067A1 (es) 1977-07-01
DK61575A (es) 1975-10-27
YU108281A (en) 1982-02-28
DE2508136B2 (de) 1978-11-02
JPS5614677B2 (es) 1981-04-06
SE410736B (sv) 1979-10-29
RO78881A (ro) 1982-07-06
DE2508136C3 (de) 1979-06-21
NO144527B (no) 1981-06-09
LU71908A1 (es) 1975-06-24
YU108381A (en) 1982-02-28
GB1499822A (en) 1978-02-01
BE826030A (fr) 1975-06-16
FR2261776B1 (es) 1978-07-21
FI56188B (fi) 1979-08-31
NO750633L (es) 1975-08-28
DK144068C (da) 1982-05-03
FI750537A (es) 1975-08-28
DE2533323B2 (de) 1978-11-16
JPS50126652A (es) 1975-10-04

Similar Documents

Publication Publication Date Title
AU501685B2 (en) D-homo-20-keto pregnanes
NZ182836A (en) 9 ,21-dihalo-6 -fluoro-11 ,17 -dihydroxy 16 -methyl-pregna-1,4-diene-3,20-diones
IE41662L (en) Androstane derivatives.
NZ181482A (en) Androsta-4 , 16-dien-3-ones
GB1517973A (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
NZ178886A (en) Estra-1,3,5(10)-triene-(3 ,7 , 17 or 3 , 7 , 17 )-triols
IE42364L (en) Hydroxyphenylacetonitriles.
MY8100137A (en) D-homo steroids
NZ178767A (en) 17a -substituted-d-homopregna-4,16-diene-3,20-diones
NZ176716A (en) 2-bromo-6b-fluoropregna-1,4-diene-3,20-diones
IL46751A (en) 2-bromo-6-9difluoro-11-hydroxy-pregna-1,4-diene-3,20-diones and process for their preparation
IL38473A0 (en) New 6alpha-fluoro-16alpha,18-dimethyl-delta1,4-pregnadiene-3,20-diones
NZ177843A (en) 9-thia,-oxothia-and-dioxothia-11,12-seco-prostaglandins
JPS5160191A (en) at katsutosuishoshindoshi
ZA756169B (en) Novel steroids
IL48208A0 (en) New corticoids
PH12638A (en) 3b-(4-oxo-a-l-rhamnosyl)b-hydroxy-bufa-4,20,22-trienolide
GB1515664A (en) Derivatives of 17alpha-hydroxy-19-norpregn-4-ene-3,20-dione
NZ182865A (en) 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones
NZ182356A (en) D-homopregna-1,4-diene -3,ii,20-triones
JPS5153496A (en) Nenshokudo nf3 kagakureezaa
AU1522976A (en) 20-cyano-20,21-epoxy steroids
JPS5160494A (en) at katsutosuishoshindoshi
JPS5173395A (en) at katsutosuishoshindoshi
AU491546B2 (en) Novel steroids